The chemical class known as RBM35B Activators consists of various compounds that indirectly enhance the activity of RBM35B, a key RNA-binding protein involved in alternative splicing regulation. These activators include Sodium Butyrate, which alters chromatin structure, promoting the transcription of genes related to splicing regulation. Curcumin influences the Wnt/β-catenin pathway, affecting splicing patterns. Resveratrol enhances RBM35B via sirtuin enzymes and splicing-related pathways. Quercetin influences kinase pathways tied to alternative splicing. Dexamethasone impacts RBM35B through stress and inflammation responses. EGCG modulates RNA splicing signaling pathways.
SB-431542 affects the TGF-β pathway linked to splicing. Staurosporine targets cellular kinases related to splicing regulation. Sodium Arsenite modulates stress responses impacting splicing. Trichostatin A alters histone deacetylases and chromatin structure, affecting splicing events. Wortmannin influences RNA splicing through cellular signaling pathways. Actinomycin D impacts RNA polymerase activity, leading to changes in splicing patterns. These compounds indirectly activate RBM35B, contributing to precise control over alternative splicing.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate can promote the activation of RBM35B by altering chromatin structure and increasing the accessibility of RNA polymerases to target genes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can indirectly activate RBM35B by modulating cellular signaling pathways, such as the Wnt/β-catenin pathway, which can influence alternative splicing events. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may enhance RBM35B activity by affecting sirtuin enzymes and downstream signaling pathways that play a role in splicing regulation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can indirectly activate RBM35B by influencing various kinase pathways that are involved in alternative splicing regulation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can indirectly impact RBM35B activity by altering the cellular response to stress and inflammation, which can influence alternative splicing patterns. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG may indirectly activate RBM35B through its influence on cellular signaling pathways involved in RNA splicing regulation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 can affect the TGF-β signaling pathway, which is known to influence alternative splicing, indirectly impacting RBM35B activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine can indirectly activate RBM35B by modulating cellular kinases involved in splicing regulation. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Sodium (meta)arsenite can indirectly influence RBM35B activity by altering cellular stress responses that impact alternative splicing. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin may indirectly influence RBM35B by impacting cellular signaling pathways, including PI3-kinase/Akt, which are linked to RNA splicing regulation. | ||||||